For clinicians

NeoGenomics is a participating provider with Medicare and Medicaid, in addition to many private insurance providers and managed care organizations.

NeoGenomics clients receive an itemized invoice that includes the date, patient’s name, accession number, test(s) performed, and test fees for each specimen completed during a given month. Please note that these invoices are payable upon receipt. If you have any questions pertaining to your account, please contact our Billing team immediately so that we may resolve them in a timely manner.

For providers who choose third-party billing, NeoGenomics will bill the patient’s insurance provider in accordance with their healthcare plan. We will work closely with your office to obtain the necessary medical documentation, including ICD-10 codes, and handle all appeals to minimize the impact for your patient.

Honoring the 14-day rule

Good faith estimate

Billing and Coding details for Myeloid Disorders

Prior authorization support for molecular & genetic testing

Molecular and genetic testing is an evolving field in oncology diagnostics, and many insurance providers have established a policy of prior authorization before testing can be performed to ensure appropriate use. NeoGenomics contracts with many national and regional healthcare insurance plans to help offer affordable testing to our patients and clients; however, each insurance plan may have a different process for obtaining prior authorization for testing.

For more specific information, NeoGenomics recommends calling the patient’s insurance plan for their current policy. For any questions or prior authorization support, please email 
priorauthorizations@neogenomics.com.